Kaeng W Lee1, Andrew D Blann, Gregory Y H Lip. 1. Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK.
Abstract
BACKGROUND: Increased circulating endothelial cells (CECs, reflecting endothelial damage) in acute coronary syndromes (ACS) has been reported. However, the inter-relationships of indices of endothelial damage/injury with development of vascular (dys)function, plasma levels of tissue factor (TF, an index of coagulation) and interleukin-6 (IL-6, a pro-inflammatory cytokine) have not been investigated in ACS. We hypothesized that increased CECs can be related to impaired flow-mediated vasodilatation (FMD, an index of endothelial dysfunction) and elevated plasma von Willebrand factor (vWf, also marking endothelial damage/dysfunction), TF and IL-6 in patients with ACS. METHODS: We studied 120 patients with ACS (80 acute myocardial infarction and 40 unstable angina; 86 male, age 65+/-12 years) and 40 matched patients with stable CAD and 40 healthy controls (HC) in a cross-sectional analysis. Plasma vWf, TF and IL-6 levels were measured by ELISA. CECs were quantified using epifluorescence microscope after immunomagnetic separation with CD146. Brachial artery FMD was assessed in a subset of 39 ACS patients. RESULTS: ACS patients had significantly higher CECs, vWf, TF and IL-6 levels, but lower FMD, when compared to stable CAD and HC (all p<0.001) and all were inter-correlated significantly. In ACS, CECs was strongly correlated with FMD (r=-0.64, p<0.001) and TF (r=0.7, p<0.001). In stable CAD, significant correlations were again found between many indices, but on multivariate analysis, IL-6 and vWf were both independently related to FMD. CONCLUSIONS: Increased CECs in ACS patients are closely associated with endothelial damage/dysfunction (vWf and FMD), coagulation (TF) and inflammation (IL-6). These inter-relationships support the concept of a central role of endothelial damage/injury in the activation of vascular and coagulation abnormalities in ACS.
BACKGROUND: Increased circulating endothelial cells (CECs, reflecting endothelial damage) in acute coronary syndromes (ACS) has been reported. However, the inter-relationships of indices of endothelial damage/injury with development of vascular (dys)function, plasma levels of tissue factor (TF, an index of coagulation) and interleukin-6 (IL-6, a pro-inflammatory cytokine) have not been investigated in ACS. We hypothesized that increased CECs can be related to impaired flow-mediated vasodilatation (FMD, an index of endothelial dysfunction) and elevated plasma von Willebrand factor (vWf, also marking endothelial damage/dysfunction), TF and IL-6 in patients with ACS. METHODS: We studied 120 patients with ACS (80 acute myocardial infarction and 40 unstable angina; 86 male, age 65+/-12 years) and 40 matched patients with stable CAD and 40 healthy controls (HC) in a cross-sectional analysis. Plasma vWf, TF and IL-6 levels were measured by ELISA. CECs were quantified using epifluorescence microscope after immunomagnetic separation with CD146. Brachial artery FMD was assessed in a subset of 39 ACS patients. RESULTS: ACS patients had significantly higher CECs, vWf, TF and IL-6 levels, but lower FMD, when compared to stable CAD and HC (all p<0.001) and all were inter-correlated significantly. In ACS, CECs was strongly correlated with FMD (r=-0.64, p<0.001) and TF (r=0.7, p<0.001). In stable CAD, significant correlations were again found between many indices, but on multivariate analysis, IL-6 and vWf were both independently related to FMD. CONCLUSIONS: Increased CECs in ACS patients are closely associated with endothelial damage/dysfunction (vWf and FMD), coagulation (TF) and inflammation (IL-6). These inter-relationships support the concept of a central role of endothelial damage/injury in the activation of vascular and coagulation abnormalities in ACS.
Authors: Christopher J Boos; Deirdre A Lane; Delene Kang; Patrick K Y Goon; Andrew D Blann; Gregory Y H Lip Journal: J Thromb Thrombolysis Date: 2006-10 Impact factor: 2.300
Authors: Justin R Ryder; Michael J O'Connell; Kyle D Rudser; Claudia K Fox; Anna N Solovey; Robert P Hebbel; Aaron S Kelly Journal: Biomark Med Date: 2016-04-13 Impact factor: 2.851
Authors: Wen Ni Tiong; Alan Yean Yip Fong; Edmund Ui Hang Sim; Hiang Chuan Chan; Tiong Kiam Ong; Boon Cheng Chang; Kui Hian Sim Journal: Heart Asia Date: 2012-10-16
Authors: Katarzyna Mizia-Stec; Maciej Haberka; Magdalena Mizia; Artur Chmiel; Klaudia Gieszczyk; Bartosz Lasota; Joanna Janowska; Barbara Zahorska-Markiewicz; Zbigniew Gąsior Journal: Arch Med Sci Date: 2011-11-08 Impact factor: 3.318
Authors: Jessica J Connelly; Tianyuan Wang; Julie E Cox; Carol Haynes; Liyong Wang; Svati H Shah; David R Crosslin; A Brent Hale; Sarah Nelson; David C Crossman; Christopher B Granger; Jonathan L Haines; Christopher J H Jones; Jeffery M Vance; Pascal J Goldschmidt-Clermont; William E Kraus; Elizabeth R Hauser; Simon G Gregory Journal: PLoS Genet Date: 2006-07-20 Impact factor: 5.917